IAM Featured Landscape

Competitive Landscape for Johnson & Johnson's Top Health Care Patent

Competetive Landscape: Johnson & Johnson

One of the unique capabilities of the Ocean Tomo Ratings™ system is the Ocean Tomo Ratings’ Relevance™ module, which is used to produce landscape maps, such as the one shown above. The first step in creating this map is to identify the top rated patent in the Johnson & Johnson portfolio, based on its OTR™ Score. This is considered the "input patent." The Ocean Tomo Ratings’ Relevance™ module then identifies other patents covering similar technology to the input patent, which is aggregated by company.

The top five companies from this aggregated dataset are shown above in the landscape map. Each bubble represents a company's relevant portfolio, with the size of each bubble representing the number of relevant patents owned by each company (including subsidiaries). Note that the Johnson & Johnson bubble represents only those patents in the Johnson & Johnson portfolio that are relevant to the input patent.

The X-axis represents the average OTR™ Score of each patent cluster, and the Y-axis represents the average relevance of each patent cluster. In the case of the Johnson & Johnson portfolio, it is naturally the most relevant as the input patent was selected from this portfolio. Working down the Y-axis, you can see other players with relevant portfolios, such as St. Jude Medical, Boston Scientific and Medtronic. Note that Boston Scientific's bubble is larger than the rest because they have a large number of patents that are relevant to the input patent. St. Jude and Medtronic have a smaller number of relevant patents, which is represented by smaller bubbles, but those patents are of higher quality, as represented by their position on the X-axis.

Ocean Tomo Ratings™ landscape maps provide valuable insight into other players in a particular space and their relationship to any input patent. From the perspective of Johnson & Johnson, Boston Scientific may be a potential threat due to its large number of patents that are relevant to the input patent. St. Jude may be viewed as a potential opportunity to enter into a licensing arrangement for its relevant and high quality patents, which could further complement Johnson & Johnson's technology.

 

---------------------------------------------

Data accessible through OceanTomo.com/ratings was prepared by Ocean Tomo based on proprietary algorithms and other statistical information provided by PatentRatings, LLC. All scores, ratings and ranks are statistical in nature and are based on publicly available data. They are not based on, nor do they consider any legal opinions or other professional opinions, advice or other information (public or otherwise) that may have bearing on the subject matter of the analysis. No direct statistical correlation has been established between OTR™ scores and "fair market value," royalty rates, validity, enforceability or infringement and OTR scores should not be relied upon to prove or establish the existence or probability of such facts. No direct statistical correlation has been established between Relevance scores and patentability or materiality, and Relevance scores should not be relied upon to prove, establish or support any opinion of the materiality or patentability of one patent in view of another. Some of the information and services provided by this website may be covered by one or more of the following U.S. patents: 6,556,992; 7,657,476; 7,716,226; and other patents pending. Copyright 2001-2013 PatentRatings, LLC. Copyright 2011-2013 Ocean Tomo, LLC. All rights reserved.